Annotation Detail for DAPK1


Gene Symbol: | DAPK1 ( DAPK,DKFZp781I035 ) |
---|---|
Gene Full Name: | death-associated protein kinase 1 |
Band: | 9q21.33 |
Quick Links | Entrez ID:1612; OMIM: 600831; Uniprot ID:DAPK1_HUMAN; ENSEMBL ID: ENSG00000196730; HGNC ID: 2674 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of DAPK1 mRNA | increases expression | 19933214 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of DAPK1 mRNA | affects expression | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of DAPK1 mRNA | affects expression | 21346803 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of DAPK1 mRNA | decreases expression | 12419474 |
C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased methylation of DAPK1 promoter | increases methylation | 15172992 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] | decreases reaction|increases expression | 19477266 |
D000082 | Acetaminophen | [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of DAPK1 mRNA | affects cotreatment|increases expression | 17093179 |
D000082 | Acetaminophen | Acetaminophen affects the expression of DAPK1 mRNA | affects expression | 17562736 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] | decreases reaction|increases expression | 19477266 |
D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in decreased expression of DAPK1 mRNA | decreases expression | 18687144 |
D001374 | Azacitidine | Azacitidine affects the methylation of DAPK1 promoter | affects methylation | 17557868 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of DAPK1 mRNA | decreases expression | 20106945 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DAPK1 mRNA | decreases expression | 19150397 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA | decreases expression | 15336504 12419474 |
D002087 | Butyrates | Butyrates results in increased expression of DAPK1 mRNA | increases expression | 16042588 |
D002784 | Cholesterol | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] | decreases reaction|increases expression | 19477266 |
D002784 | Cholesterol | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of DAPK1 mRNA] | decreases reaction|increases expression | 19477266 |
D002784 | Cholesterol | Cholesterol analog results in increased expression of DAPK1 mRNA | increases expression | 19477266 |
C014347 | decitabine | decitabine affects the expression of DAPK1 mRNA | affects expression | 17133271 |
C014347 | decitabine | decitabine inhibits the reaction [sodium arsenite results in decreased expression of DAPK1 protein] | decreases expression|decreases reaction | 19577553 |
C014347 | decitabine | decitabine results in decreased methylation of DAPK1 promoter | decreases methylation | 17690560 |
C014347 | decitabine | decitabine results in increased expression of DAPK1 mRNA | increases expression | 19037991 19215824 |
D004040 | Dietary Carbohydrates | [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of DAPK1 mRNA | affects cotreatment|increases expression | 17093179 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of DAPK1 protein | affects cotreatment|decreases expression | 20970405 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of DAPK1 promoter | affects cotreatment|increases methylation | 20970405 |
D002117 | Calcitriol | Calcitriol results in decreased expression of DAPK1 mRNA | decreases expression | 16002434 |
C025034 | doxifluridine | DAPK1 protein results in increased susceptibility to doxifluridine | increases response to substance | 16734730 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of DAPK1 mRNA | decreases expression | 12628509 |
D004958 | Estradiol | Estradiol results in decreased expression of DAPK1 mRNA | decreases expression | 16202921 |
D006830 | Hydralazine | Hydralazine results in decreased methylation of DAPK1 promoter | decreases methylation | 15862127 |
D006830 | Hydralazine | Hydralazine results in increased expression of DAPK1 mRNA | increases expression | 15862127 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of DAPK1 mRNA | decreases expression | 12419474 |
D008748 | Methylcholanthrene | [Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of DAPK1 protein | affects cotreatment|decreases expression | 20970405 |
D008748 | Methylcholanthrene | [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of DAPK1 promoter | affects cotreatment|increases methylation | 20970405 |
D008752 | Methylene Chloride | Methylene Chloride results in increased methylation of DAPK1 promoter | increases methylation | 15172992 |
D008942 | Mitoxantrone | DAPK1 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747 |
C064769 | N-acetylsphingosine | N-acetylsphingosine results in increased activity of DAPK1 protein | increases activity | 17087515 |
C064769 | N-acetylsphingosine | N-acetylsphingosine results in increased activity of DAPK1 protein | increases activity | 17087515 |
D010656 | Phenylephrine | Phenylephrine results in decreased expression of DAPK1 mRNA | decreases expression | 18158353 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DAPK1 mRNA | affects binding|decreases expression|increases activity | 19710929 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DAPK1 mRNA | affects binding|increases activity|increases expression | 19710929 |
C017947 | sodium arsenite | decitabine inhibits the reaction [sodium arsenite results in decreased expression of DAPK1 protein] | decreases expression|decreases reaction | 19577553 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of DAPK1 protein | decreases expression | 19577553 |
C017947 | sodium arsenite | sodium arsenite results in increased methylation of DAPK1 promoter | increases methylation | 17683884 19577553 |
C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in decreased expression of DAPK1 protein] | decreases expression|decreases reaction | 19577553 |
D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of DAPK1 mRNA | decreases expression | 18175754 16705456 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of DAPK1 mRNA | increases expression | 15972635 19933214 |
D014212 | Tretinoin | Tretinoin results in increased expression of DAPK1 mRNA | increases expression | 16249480 |
C012589 | trichostatin A | trichostatin A results in increased expression of DAPK1 mRNA | increases expression | 16865256 |
C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in decreased expression of DAPK1 protein] | decreases expression|decreases reaction | 19577553 |
C025643 | vinclozolin | vinclozolin affects the expression of DAPK1 mRNA | affects expression | 19015723 |
C017963 | vinyl carbamate | vinyl carbamate results in increased methylation of DAPK1 promoter | increases methylation | 15172992 |
C088658 | zoledronic acid | zoledronic acid results in decreased expression of DAPK1 mRNA | decreases expression | 19036117 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.45 | 11752688 14514962 15322242 | |
MESH:D000168 | Acrocephalosyndactylia | U 0126 | 5.08 | 17694057 | |
MESH:D058186 | Acute Kidney Injury | zoledronic acid | 4.10 | 19715164 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 2.75 | 18653653 | |
MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 5.07 | 20200999 | |
MESH:D000230 | Adenocarcinoma | marker/mechanism | 15172992 | ||
MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 6.59 | 20127859 20464547 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 6.59 | 11473722 | |
MESH:D000230 | Adenocarcinoma | vinyl carbamate | 6.59 | 16247444 17363558 | |
MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 14.05 | 16176798 | |
MESH:D000236 | Adenoma | Benzo(a)pyrene | 14.05 | 6695378 | |
MESH:D000236 | Adenoma | Diethylnitrosamine | 14.05 | 10737359 6695378 | |
MESH:D000236 | Adenoma | Methylcholanthrene | 14.05 | 10545420 6695378 | |
MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 21.59 | 16434500 19061943 17162532 17620307 18056438 19052882 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 21.59 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 21.59 | 16835633 | |
MESH:D018248 | Adenoma, Liver Cell | vinyl carbamate | 21.59 | 12371669 | |
MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 4.28 | 15276417 | |
MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 4.49 | 17306315 16712894 | |
MESH:D000505 | Alopecia | Tretinoin | 3.29 | 15955085 | |
MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 3.84 | 10965797 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.60 | 11748828 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.43 | 10982225 | |
MESH:D001008 | Anxiety Disorders | vinclozolin | 3.32 | 19015723 | |
MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 3.68 | 19183758 | |
MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 3.76 | 17460149 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 2.82 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 2.16 | 16292516 | |
MESH:D001249 | Asthma | epigallocatechin gallate | 4.77 | 16516891 | |
MESH:D001249 | Asthma | Tretinoin | 4.77 | 16456186 | |
MESH:D050197 | Atherosclerosis | Cholesterol | 6.50 | 16632123 | |
MESH:D050197 | Atherosclerosis | Methylcholanthrene | 6.50 | 11922910 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 1.46 | 18445737 | |
MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 4.67 | 19761891 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 4.02 | 16935849 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 13.17 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 13.17 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 13.17 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.38 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.50 | 15746008 | |
MESH:D001859 | Bone Neoplasms | zoledronic acid | 4.58 | 11697798 16121404 17312309 15867366 16778634 19442620 | |
MESH:D001862 | Bone Resorption | zoledronic acid | 4.34 | 18404659 18496637 15845617 16769263 11869084 8053405 | |
MESH:D001919 | Bradycardia | Phenylephrine | 4.14 | 15306635 | |
MESH:D001932 | Brain Neoplasms | marker/mechanism | 17319784 | ||
MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 7.71 | 20146248 | |
MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 7.71 | 20146248 17474063 | |
MESH:D001943 | Breast Neoplasms | Calcitriol | 7.71 | 11237771 | |
MESH:D001943 | Breast Neoplasms | decitabine | 7.71 | 18320071 19208741 | |
MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 7.71 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 7.71 | 17289903 18497071 12948864 17018787 16675129 14630087 17261762 19861407 | |
MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 7.71 | 17474063 | |
MESH:D001943 | Breast Neoplasms | Methylene Chloride | 7.71 | 15986119 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 7.71 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 7.71 | 16166294 16443354 16873071 | |
MESH:D001943 | Breast Neoplasms | zoledronic acid | 7.71 | 18695136 16096432 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.18 | 16813970 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 4.06 | 16111702 | |
MESH:D002277 | Carcinoma | Methylcholanthrene | 7.27 | 10545420 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 7.27 | 16835633 | |
MESH:D003528 | Carcinoma, Adenoid Cystic | marker/mechanism | 16762588 | ||
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.74 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 15.54 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 15.54 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 15.54 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 15.54 | 16502159 19383236 19171122 10737359 17138121 18785209 16569478 19418558 20727157 20512989 19052882 20101231 17978847 18665156 16878318 16698587 16935385 19519916 3084413 20084675 20214788 18691550 17761372 20432363 16288022 16681979 17173139 19394651 19919837 20514400 19208518 17428255 18788625 17055752 18506893 18971187 16328049 17162532 19701751 3581430 18393292 19107877 20007298 16830150 19822196 21159647 20524982 19335982 18210153 16807293 19539802 20935162 10672840 11831363 16779866 18494052 18056438 16540662 18978308 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 15.54 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 15.54 | 15276417 17306315 16507464 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 15.54 | 1917145 | |
MESH:D006528 | Carcinoma, Hepatocellular | vinyl carbamate | 15.54 | 12371669 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | marker/mechanism | 11313923 | ||
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | vinyl carbamate | 5.89 | 16247446 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 5.89 | 19233551 | |
MESH:D002292 | Carcinoma, Renal Cell | marker/mechanism | 17133271 | ||
MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 3.65 | 18507039 | |
MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 16.34 | 17015178 | |
MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 16.34 | 20419170 | |
MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 16.34 | 11237771 | |
MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 16.34 | 19215824 | |
MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 16.34 | 18572023 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 16.34 | 16051514 16096774 | |
MESH:D002295 | Carcinoma, Transitional Cell | marker/mechanism | 17133271 | ||
MESH:D006332 | Cardiomegaly | Phenylephrine | 6.11 | 11179087 16170337 17124262 17287366 15728586 11754973 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 6.11 | 16120746 18670907 18850075 | |
MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 3.23 | 16936243 | |
MESH:D002386 | Cataract | Acetaminophen | 6.41 | 10977129 | |
MESH:D002386 | Cataract | Tretinoin | 6.41 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 27.47 | 6135515 | |
MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 27.47 | 20889678 | |
MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 27.47 | 18226522 | |
MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 27.47 | 21159647 17174075 7505956 2727394 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 27.47 | 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 27.47 | 16192471 | |
MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 27.47 | 20056578 19524636 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.18 | 16129372 | |
MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 8.19 | 19052882 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 8.19 | 16835633 | |
MESH:D002779 | Cholestasis | pirinixic acid | 2.53 | 19176532 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.74 | 16461808 | |
MESH:D019457 | Chromosome Breakage | Sodium Selenite | 4.35 | 15894690 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.16 | 12621046 8697196 15668235 16354765 15340226 | |
MESH:D002972 | Cleft Palate | Tretinoin | 5.16 | 9407595 | |
MESH:D003092 | Colitis | Tretinoin | 3.31 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | Butyrates | 3.89 | 15936596 | |
MESH:D003110 | Colonic Neoplasms | decitabine | 3.89 | 17616700 | |
MESH:D015179 | Colorectal Neoplasms | Azacitidine | 2.79 | 19934284 | |
MESH:D015179 | Colorectal Neoplasms | decitabine | 2.79 | 18981723 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.72 | 17141729 14669216 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 2.31 | 15322242 10048152 20055451 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 2.31 | 9142499 16925845 8800419 10589399 9211117 17551590 9664655 14991402 9224671 9125849 | |
MESH:D003456 | Cryptorchidism | vinclozolin | 3.95 | 14966744 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 9.57 | 18551238 | |
MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 9.57 | 18551238 | |
MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 4.03 | 19747007 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 2.23 | 18249437 | |
MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 3.44 | 16285004 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 6.54 | 20387270 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 6.54 | 16988119 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 6.54 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 3.07 | 19279558 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 16.58 | 21346803 18551238 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 16.58 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 16.58 | 10663392 17906064 15619225 19085960 14550746 19739265 12540782 11743745 12153990 10915739 12392966 16081117 19420014 16781746 11529661 14725611 10774834 14986274 19923254 16109766 12958197 16177239 11834606 11461765 17562736 19416960 2444490 11287661 11421492 11739529 16227642 12705907 19164858 18713872 12594235 15968718 19370779 18071297 17522070 16393943 16485898 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 16.58 | 11287661 | |
MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 16.58 | 19107877 | |
MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 16.58 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 16.58 | 20420201 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.68 | 19426721 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.46 | 11462148 | |
MESH:D004487 | Edema | pirinixic acid | 5.36 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 5.36 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 10.56 | 16714409 15322242 18230668 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 10.56 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 3.55 | 15138306 | |
MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 12.65 | 19294695 | |
MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 12.65 | 19294695 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 6.52 | 19148513 18566989 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 6.52 | 16569247 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 2.67 | 10568697 9294722 | |
MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 4.70 | 16302075 | |
MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 3.96 | 20426865 | |
MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 3.96 | 16530937 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 7.83 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 7.83 | 9664655 16938888 | |
MESH:D005234 | Fatty Liver | Diethylnitrosamine | 6.49 | 21071580 20387270 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 6.49 | 19236843 20131406 | |
MESH:D005264 | Femoral Fractures | zoledronic acid | 5.42 | 16234978 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.06 | 11858732 | |
MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 4.53 | 14633661 10962813 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 7.30 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 7.30 | 17994277 | |
MESH:D005756 | Gastritis | Acetaminophen | 3.26 | 16983495 | |
MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 4.53 | 16973722 | |
MESH:D005832 | Genital Diseases, Male | vinclozolin | 4.89 | 16417039 | |
MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 4.27 | 16452187 | |
MESH:D005909 | Glioblastoma | Tretinoin | 6.53 | 17312396 | |
MESH:D005909 | Glioblastoma | trichostatin A | 6.53 | 18801729 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.18 | 10696789 | |
MESH:D006258 | Head and Neck Neoplasms | decitabine | 6.91 | 19215824 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 6.91 | 16096774 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.74 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 9.80 | 20471113 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 9.80 | 11294989 10048152 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 9.80 | 9664655 14991402 | |
MESH:D006331 | Heart Diseases | Mitoxantrone | 3.87 | 16019553 | |
MESH:D006333 | Heart Failure | pirinixic acid | 2.28 | 20558911 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.97 | 11000095 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 6.95 | 16221962 19772884 18467677 19176532 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 6.95 | 15340226 16120746 12621046 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.62 | 15709030 | |
MESH:D006689 | Hodgkin Disease | sodium arsenite | 2.82 | 12676792 | |
MESH:D019584 | Hot Flashes | Estradiol | 3.34 | 17088409 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.63 | 15340226 18606429 8697196 16354765 16959395 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 11.29 | 16870215 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 11.29 | 16870215 | |
MESH:D006930 | Hyperalgesia | zoledronic acid | 11.29 | 16769263 | |
MESH:D006934 | Hypercalcemia | zoledronic acid | 4.68 | 19622757 18089816 | |
MESH:D006937 | Hypercholesterolemia | Cholesterol | 4.61 | 16933029 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.17 | 16778211 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 2.83 | 20558911 | |
MESH:D006973 | Hypertension | Phenylephrine | 4.75 | 12717712 8949925 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 4.75 | 18670907 18850075 | |
MESH:D046110 | Hypertension, Pregnancy-Induced | Hydralazine | 4.23 | 16612254 | |
MESH:D006984 | Hypertrophy | Phenylephrine | 4.19 | 12791704 18502941 | |
MESH:D006996 | Hypocalcemia | zoledronic acid | 5.78 | 12669777 | |
MESH:D007248 | Infertility, Male | decitabine | 9.71 | 17581917 | |
MESH:D007248 | Infertility, Male | sodium arsenite | 9.71 | 15346721 12646999 | |
MESH:D007248 | Infertility, Male | vinclozolin | 9.71 | 16467254 | |
MESH:D007249 | Inflammation | Diethylnitrosamine | 4.18 | 18785209 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 4.18 | 12878042 12200463 | |
MESH:D007333 | Insulin Resistance | Estradiol | 10.75 | 16627594 16393666 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 10.75 | 16306350 | |
MESH:D007333 | Insulin Resistance | Sodium Selenite | 10.75 | 14714311 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.37 | 17994277 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 8.72 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 8.72 | 15992940 17551590 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 8.64 | 15629191 12587719 | |
MESH:D007674 | Kidney Diseases | Estradiol | 8.64 | 15618244 | |
MESH:D007674 | Kidney Diseases | sodium arsenite | 8.64 | 20008137 | |
MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 3.91 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 10.50 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 10.50 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 10.50 | 15610895 | |
MESH:D007859 | Learning Disorders | Cholesterol | 4.70 | 17134702 | |
MESH:D007938 | Leukemia | Azacitidine | 9.39 | 19148494 | |
MESH:D007938 | Leukemia | decitabine | 9.39 | 19235587 18980019 | |
MESH:D007938 | Leukemia | Tretinoin | 9.39 | 17143497 | |
MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Mitoxantrone | 3.61 | 18172266 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 4.41 | 18089816 | |
MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 4.90 | 16972261 | |
MESH:D007951 | Leukemia, Myeloid | Azacitidine | 14.02 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | decitabine | 14.02 | 19117987 18454857 17236224 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 14.02 | 19285840 16932348 16482212 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 8.10 | 18720364 17596541 | |
MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 8.10 | 19387464 18704418 18206229 18460780 17679729 19010910 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 8.10 | 19850784 17596541 16294345 | |
MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 8.10 | 18206229 | |
MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 5.05 | 18055864 | |
MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 4.82 | 19299654 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 2.88 | 17217047 16788101 12679006 17649720 17506722 19225113 16140955 19075265 16331271 19029980 15748426 17361223 16766008 17294898 17368321 17301526 9834237 16823087 17712046 19035177 19642359 17107899 16935935 17339181 16891316 | |
MESH:D007984 | Leydig Cell Tumor | vinclozolin | 4.32 | 16417039 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 3.02 | 9224671 | |
MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 2.60 | 20032147 19638242 18522880 18407596 18665156 | |
MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 6.10 | 17481882 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 6.10 | 14716833 14659978 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 6.10 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 6.10 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 6.10 | 16248980 18397230 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 3.52 | 19460945 11587558 12587719 16611625 19784758 16610002 12969438 19014921 | |
MESH:D008107 | Liver Diseases | Diethylnitrosamine | 3.52 | 17034775 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 2.88 | 16871587 17185352 | |
MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 19.32 | 7678174 | |
MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 19.32 | 15890375 | |
MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 19.32 | 21137059 20195826 | |
MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 19.32 | 19427195 19833225 19690152 21047994 16942905 21167192 19426721 20434301 20101389 20405173 18977376 20118626 12112319 19073162 21278145 19642983 18754104 20501860 19638242 21071580 19294768 20583210 20137499 19996281 12771043 19090486 19812893 20492335 18644402 19850985 19499222 18978307 19254457 19551842 20452335 10737359 15175105 19255062 18648771 2422723 9163691 2862719 15885732 19256749 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 19.32 | 20007298 16377806 15890375 | |
MESH:D008113 | Liver Neoplasms | sodium arsenite | 19.32 | 16712894 15276417 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 19.32 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 12.00 | 6135515 2876784 2876786 | |
MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 12.00 | 18775883 17942915 18544905 9362446 16267830 17174075 18079962 19004024 19009564 21159647 18253720 18282651 18164116 2563599 19126423 18308698 18093689 19519916 19539802 3124819 16842330 17854601 | |
MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 12.00 | 598648 1399818 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 12.00 | 12151625 | |
MESH:D008171 | Lung Diseases | Acetylcysteine | 6.85 | 12815614 | |
MESH:D008171 | Lung Diseases | sodium arsenite | 6.85 | 19095001 | |
MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 3.63 | 17365036 | |
MESH:D008175 | Lung Neoplasms | marker/mechanism | 15172992 | ||
MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 14.21 | 19931552 17139156 9255578 16061637 14755239 16401635 18508827 18813816 15893417 15172992 12438228 | |
MESH:D008175 | Lung Neoplasms | Azacitidine | 14.21 | 21224363 | |
MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 14.21 | 20064080 18569708 20869020 18816296 18520028 20464547 17053015 6695378 20135361 | |
MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 14.21 | 20512841 20970405 21163286 6695378 | |
MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 14.21 | 1399818 21163286 7750092 6695378 16337739 20512841 15390079 16271038 11893704 20970405 10545420 9230183 17909032 | |
MESH:D008175 | Lung Neoplasms | Methylene Chloride | 14.21 | 15172992 | |
MESH:D008175 | Lung Neoplasms | sodium arsenite | 14.21 | 17077188 15276417 17306315 19931552 16712894 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 14.21 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | vinyl carbamate | 14.21 | 12438228 14755239 15172992 17363558 16885199 16247444 12765245 11195469 15824018 11134547 17361011 17163412 12117777 | |
MESH:D008223 | Lymphoma | decitabine | 3.13 | 19470736 | |
MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 3.68 | 14737004 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 5.50 | 11408345 11807958 16891317 17203775 | |
MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 5.50 | 17312309 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 4.07 | 19453300 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.62 | 17453147 | |
MESH:D008545 | Melanoma | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 11.41 | 17992120 | |
MESH:D008545 | Melanoma | decitabine | 11.41 | 16505122 17785578 | |
MESH:D008545 | Melanoma | epigallocatechin gallate | 11.41 | 17992120 11746506 | |
MESH:D008545 | Melanoma | sodium arsenite | 11.41 | 19082730 16487513 | |
MESH:D008545 | Melanoma | Tretinoin | 11.41 | 16752155 | |
MESH:D008545 | Melanoma | trichostatin A | 11.41 | 16505122 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 3.17 | 19513568 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 4.03 | 16940565 | |
MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 6.11 | 16166281 16966607 18303189 | |
MESH:D008654 | Mesothelioma | zoledronic acid | 6.11 | 16675582 | |
MESH:D009006 | Monosomy | Azacitidine | 5.67 | 19299654 | |
MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 2.88 | 16381670 | |
MESH:D009101 | Multiple Myeloma | Azacitidine | 15.00 | 19549372 18443271 | |
MESH:D009101 | Multiple Myeloma | decitabine | 15.00 | 18172295 | |
MESH:D009101 | Multiple Myeloma | trichostatin A | 15.00 | 18172295 | |
MESH:D009101 | Multiple Myeloma | zoledronic acid | 15.00 | 19621390 18089719 16996129 | |
MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 5.08 | 17962980 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 3.11 | 16239165 | |
MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 11.07 | 18720364 19805378 17611569 17596541 | |
MESH:D009190 | Myelodysplastic Syndromes | decitabine | 11.07 | 19010910 16882708 19157545 18608210 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 11.07 | 17596541 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 1.97 | 19151258 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 2.70 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 7.22 | 16810080 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 7.22 | 16411023 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 8.99 | 18551238 | |
MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 8.99 | 7678174 18551238 | |
MESH:D009362 | Neoplasm Metastasis | marker/mechanism | 17319784 | ||
MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 8.74 | 14720322 | |
MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 8.74 | 9029167 3581430 | |
MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 8.74 | 15867366 17312309 19139120 | |
MESH:D009369 | Neoplasms | Benzo(a)pyrene | 17.05 | 11141357 | |
MESH:D009369 | Neoplasms | decitabine | 17.05 | 19470736 19116145 17925555 | |
MESH:D009369 | Neoplasms | Mitoxantrone | 17.05 | 16640825 | |
MESH:D009369 | Neoplasms | pirinixic acid | 17.05 | 17405874 | |
MESH:D009369 | Neoplasms | sodium arsenite | 17.05 | 11559025 | |
MESH:D009369 | Neoplasms | Tretinoin | 17.05 | 16594593 16946489 | |
MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 3.27 | 20056578 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 3.33 | 17289903 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 14.10 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 14.10 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 14.10 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Acetylcysteine | 10.72 | 19446573 | |
MESH:D009436 | Neural Tube Defects | sodium arsenite | 10.72 | 12854658 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 10.72 | 9142499 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 7.09 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 7.09 | 20387270 | |
MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 4.70 | 20387270 | |
MESH:D052556 | Niemann-Pick Disease, Type C | Cholesterol | 5.31 | 20557099 9802331 | |
MESH:D009765 | Obesity | pirinixic acid | 1.71 | 20558911 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 7.72 | 12819281 16049721 | |
MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 7.72 | 16049721 | |
MESH:D010014 | Osteolysis | zoledronic acid | 4.96 | 15867366 | |
MESH:D010024 | Osteoporosis | zoledronic acid | 3.78 | 17882678 | |
MESH:D010051 | Ovarian Neoplasms | decitabine | 17.02 | 19331143 19259094 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 17.02 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 17.02 | 15276417 17306315 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 17.02 | 16936753 | |
MESH:D010051 | Ovarian Neoplasms | trichostatin A | 17.02 | 19331143 | |
MESH:D010051 | Ovarian Neoplasms | U 0126 | 17.02 | 16211241 | |
MESH:D010146 | Pain | Acetaminophen | 9.45 | 16870215 | |
MESH:D010146 | Pain | Tretinoin | 9.45 | 16870215 | |
MESH:D010146 | Pain | zoledronic acid | 9.45 | 16475674 | |
MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 14.64 | 12384795 | |
MESH:D010190 | Pancreatic Neoplasms | decitabine | 14.64 | 19294695 | |
MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 14.64 | 16540662 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 14.64 | 15976015 | |
MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 14.64 | 19294695 | |
MESH:D010212 | Papilloma | Hydrogen Peroxide | 3.69 | 12065085 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.83 | 12520081 | |
MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 5.09 | 11550810 | |
MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 4.50 | 10923243 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.17 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 3.21 | 2563599 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 8.14 | 11118676 11896295 11222880 11399792 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 8.14 | 18042343 18220299 19015723 | |
MESH:D055728 | Primary Myelofibrosis | decitabine | 11.10 | 17616702 | |
MESH:D055728 | Primary Myelofibrosis | trichostatin A | 11.10 | 17616702 | |
MESH:D011469 | Prostatic Diseases | vinclozolin | 4.53 | 18220299 | |
MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 4.37 | 15572423 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 3.52 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | Azacitidine | 2.34 | 18324645 | |
MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.34 | 17292933 | |
MESH:D011471 | Prostatic Neoplasms | Calcitriol | 2.34 | 12479363 18247401 16289102 15754350 16644109 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 2.34 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 2.34 | 16039940 | |
MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 2.34 | 18760546 | |
MESH:D011471 | Prostatic Neoplasms | trichostatin A | 2.34 | 19789329 18798265 | |
MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 2.34 | 12438248 19103299 | |
MESH:D011472 | Prostatitis | vinclozolin | 4.53 | 18629315 | |
MESH:D011507 | Proteinuria | Tretinoin | 3.23 | 16636307 | |
MESH:D011625 | Pterygium | Tretinoin | 4.38 | 16723453 | |
MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 2.87 | 17365031 17322281 17975199 15814490 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 2.18 | 19058328 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 4.15 | 12210543 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.45 | 18990726 | |
MESH:D012208 | Rhabdomyosarcoma | decitabine | 9.70 | 19155313 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 9.70 | 16116481 16283617 | |
MESH:D012468 | Salivary Gland Neoplasms | marker/mechanism | 16762588 | ||
MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 4.55 | 16121404 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 4.95 | 18551238 | |
MESH:D012640 | Seizures | 2,6-dinitrotoluene | 4.95 | 18551238 | |
MESH:D012852 | Sinusitis | Phenylephrine | 4.30 | 7327846 | |
MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 19.85 | 10029692 19755658 | |
MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 19.85 | 12065085 | |
MESH:D012878 | Skin Neoplasms | sodium arsenite | 19.85 | 19524636 18572023 | |
MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 19.85 | 8532709 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 19.85 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 19.85 | 16467112 | |
MESH:D016135 | Spinal Dysraphism | sodium arsenite | 3.48 | 12854658 | |
MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 4.32 | 2093021 20155912 | |
MESH:D013274 | Stomach Neoplasms | decitabine | 4.32 | 19037991 | |
MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 4.32 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 4.32 | 17261132 | |
MESH:D013276 | Stomach Ulcer | Acetylcysteine | 3.65 | 17918041 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 3.49 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Butyrates | 14.63 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | decitabine | 14.63 | 17967635 | |
MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 14.63 | 7505956 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 14.63 | 16026305 17045167 | |
MESH:D013978 | Tibial Fractures | Estradiol | 4.27 | 19048282 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 3.44 | 16051514 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.97 | 16040207 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 13.96 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 13.96 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 13.96 | 17053015 | |
MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 13.96 | 17616700 19087683 | |
MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 13.96 | 16452187 16712894 11723127 17306315 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 10.63 | 10091137 | |
MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 10.63 | 10091137 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.61 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 8.24 | 11813266 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 8.24 | 16129372 | |
MESH:D014604 | Uveal Neoplasms | decitabine | 11.45 | 17785578 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 11.45 | 16752155 | |
MESH:D014652 | Vascular Diseases | sodium arsenite | 4.02 | 17056641 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.18 | 12125929 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.67 | 16761959 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.83 | 15886252 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.63 | 16287080 |
Pathway ID | Pathway Name |
---|---|
REACT:578 | Apoptosis |
KEGG:05219 | Bladder cancer |
KEGG:05200 | Pathways in cancer |